Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis


HALİL M. G. , Cankurtaran M., DOĞU B. B. , Ulger Z., Piskinpasa S., Gedik A., ...More

ANNALS OF PHARMACOTHERAPY, vol.41, no.1, pp.41-45, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.1345/aph.1h506
  • Journal Name: ANNALS OF PHARMACOTHERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.41-45
  • Hacettepe University Affiliated: Yes

Abstract

BACKGROUND: Strontium ranelate offers significant clinical terms of efficacy, tolerability, and ease of administration in the treatment of postmenopausal osteoporosis. However, there are some data revealing an association between strontium ranelate treatment and increased incidence of venous thromboembolism (VTE), suggesting possible adverse prothrombotic effects of the drug.